Cirena, Inc. is a biotechnology company focused on the chemical synthesis of RNA and other nucleic acid materials. It develops and supplies long RNA oligonucleotides and related reagents for applications in gene editing, therapeutics development, and life‑science research.
The company emphasizes scalable, efficient manufacturing methods to deliver high‑quality long‑chain RNA to pharmaceutical, biotechnology, and academic customers, supporting needs from discovery through early development.
None yet. When a new project in the record names Cirena as owner, partner or investor, it shows here.
MGC and Cirena to negotiate exclusive Japan distribution for long-chain RNA, enhancing MGC's nucleic acid pharmaceutical efforts.
